raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:252054

Hemangioblastoma

Type
Disease
Group
Disorder
Age of onset
Adult
Status
active

A rare benign, highly vascularized tumor characterized by various symptoms depending on the location. They typically occur in the brain (typically cerebellum, in addition to brainstem, cerebrum) and spinal cord, and predominantly affect the central nervous system. However they can also be found in peripheral nerves, bone and soft tissue, liver, lung, pancreas, kidney, intestines, and skin in a lesser extent. They most commonly occur sporadically or in association with von Hippel-Lindau syndrome. Patients having cerebellar tumors often present with headaches, nausea, vomiting, and signs of increased intracranial pressure, whereas patients having brainstem tumors develop motor and sensory deficits, ataxia, and potentially fatal hemorrhages. Hemangioblastomas located in spinal cord may result in localized pain, motor weakness, sensory disturbances, and bowel or bladder dysfunction. Patients having optic nerve hemangioblastoma were also reported of either being asymptomatic or manifest vision loss, proptosis, and pain.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enHemangioblastoma
frHémangioblastome
deHämangioblastom
esHemangioblastoma
itEmangioblastoma
nlHemangioblastoom
ptHemangioblastoma
plNaczyniak krwionośny zarodkowy
csHemangioblastom
ukГемангіобластома
zh血管母细胞瘤
trHemanjiyoblastom

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10D33.4BTNTattributedvalidated
ICD-10D33.7BTNTattributedvalidated
MONDO0016748Evalidated
MeSHD018325Evalidated
UMLSC0206734Evalidated
GARD8232Evalidated
MedDRA10018813Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 1 000 0000.14 / 100 000WorldwideValue and classValidated39163468[PMID]_ORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

16 annotations · validated 2017-09-06
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0010797Hemangioblastoma
Very frequent (99-80%)
HP:0030915Cerebellar edema
HP:0006880Cerebellar hemangioblastoma
HP:0002315Headache
HP:0010576Intracranial cystic lesion
HP:0002017Nausea and vomiting
HP:0009711Retinal capillary hemangioma
HP:0002321Vertigo
Frequent (79-30%)
HP:0012534Dysesthesia
HP:0030144Hypoactive bowel sounds
HP:0007340Lower limb muscle weakness
HP:0000011Neurogenic bladder
HP:0009713Spinal hemangioblastoma
HP:0100661Trigeminal neuralgia
HP:0003484Upper limb muscle weakness
Occasional (29-5%)
HP:0000238Hydrocephalus

Run the differential on the 8 obligate / very frequent terms

Annotation source: 25634201[PMID]_12946211[PMID]_10658709[PMID]_361212[PMID]_4926822[PMID]

7

Sources for this card